Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 81 (1), 63-9

Lack of in Vivo Mutagenicity and Oxidative DNA Damage by Flumequine in the Livers of Gpt Delta Mice

Affiliations

Lack of in Vivo Mutagenicity and Oxidative DNA Damage by Flumequine in the Livers of Gpt Delta Mice

Yuichi Kuroiwa et al. Arch Toxicol.

Abstract

Flumequine (FLU), an anti-bacterial quinolone agent, has been recognized as a non-genotoxic carcinogen for the mouse liver, but recent reports have suggested that some genotoxic mechanism involving oxidative DNA damage may be responsible for its hepatocarcinogenesis. In the present study, we investigated this possibility in the mouse liver using male and female B6C3F1 gpt delta mice fed diet containing 0.4% FLU, a carcinogenic dose, for 13 weeks. Measurements of 8-hydroxydeoxyguanosine levels in liver DNA, and gpt point and deletion mutations revealed no significant increases in any of these parameters in either sex. Histopathologically, centrilobular swelling of hepatocytes with vacuolation was apparent, however, together with significant increase in bromodeoxyuridine-labeling indices in the treated males and females. These results suggest that genotoxicity, including oxidative DNA damage, is not involved in mouse hepatocarcinogenesis by FLU, which might rather solely exert tumor-promoting effects in the liver.

Similar articles

See all similar articles

Cited by 1 PubMed Central articles

  • Thresholds of Genotoxic and Non-Genotoxic Carcinogens
    T Nohmi. Toxicol Res 34 (4), 281-290. PMID 30370002. - Review
    Exposure to chemical agents is an inevitable consequence of modern society; some of these agents are hazardous to human health. The effects of chemical carcinogens are of …

Publication types

MeSH terms

LinkOut - more resources

Feedback